Frank Slattery increased its stake in Apple Inc (Call) (AAPL) by 60% based on its latest 2018Q1 regulatory filing with the SEC. Symmetry Peak Management Llc bought 15,000 shares as the company’s stock rose 5.37% while stock markets declined. The hedge fund run by Frank Slattery held 40,000 shares of the computer manufacturing company at the end of 2018Q1, valued at $6.71M, up from 25,000 at the end of the previous reported quarter. Symmetry Peak Management Llc who had been investing in Apple Inc (Call) for a number of months, seems to be bullish on the $912.69 billion market cap company. The stock decreased 1.62% or $3.05 during the last trading session, reaching $185.69. About 29.26 million shares traded. Apple Inc. (NASDAQ:AAPL) has risen 22.56% since June 20, 2017 and is uptrending. It has outperformed by 9.99% the S&P500. Some Historical AAPL News: 16/04/2018 – Apple planned to release a gold iPhone X but scrapped it; 01/05/2018 – Puget Sound Business Journal: At Two Union, Regus is moving out to make way for a growing Apple, sources tell @MarcStilesPSBJ:; 04/04/2018 – Bloomberg TV: EXCLUSIVE: Apple is working on touchless control and a curved iPhone screen; 07/05/2018 – BUFFETT SAYS DOES NOT BELIEVE U.S. WILL HAVE A TRADE WAR OF SIGNIFICANCE WITH CHINA; 15/03/2018 – Jabil, Apple Contractor, Rises on FYQ2 Beat, CEO Sees ‘Broad-based Growth’ — Barron’s Blog; 09/04/2018 – Amazon spent nearly $23 billion on R&D last year – more than any other U.S. company. It’s followed in spending by: ✅ Alphabet – $16.6 billion ✅ Intel – $13.1 billion ✅ Microsoft – $12.3 billion ✅ Apple – $11; 09/04/2018 – In need of an Apple upgrade? These new red iPhone 8 and iPhone 8 Plus have hit the market; 28/05/2018 – IPhone Screen Makers Fall on Report of Apple OLED Shift in 2019; 29/03/2018 – APPLE TO REVAMP PRIVACY CONTROLS TO COMPLY WITH NEW EU LAW; 01/05/2018 – Apple Sees 3Q Other Income $400M
Css Llc increased its stake in Teva Pharmaceutical Inds Ltd (Put) (TEVA) by 162.73% based on its latest 2018Q1 regulatory filing with the SEC. Css Llc bought 99,100 shares as the company’s stock rose 10.90% while stock markets declined. The institutional investor held 160,000 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $2.74M, up from 60,900 at the end of the previous reported quarter. Css Llc who had been investing in Teva Pharmaceutical Inds Ltd (Put) for a number of months, seems to be bullish on the $24.49 billion market cap company. The stock decreased 0.70% or $0.17 during the last trading session, reaching $24.05. About 8.75 million shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 22.74% since June 20, 2017 and is downtrending. It has underperformed by 35.31% the S&P500. Some Historical TEVA News: 18/05/2018 – HIKMA PHARMACEUTICALS – STUDY FOR GENERIC ADVAIR STUDY IS PROCEEDING AS PLANNED, EXPECT TO SUBMIT RESPONSE TO FDA WITH NEW CLINICAL DATA AS EARLY AS POSSIBLE IN 2019; 10/05/2018 – TEVA CANADA REPORTS LAUNCH OF TEVA-CYCLOSPORINE® OPHTHALMIC EMU; 03/05/2018 – SCHULTZ SAYS THERE ARE NO M&A PLANS FOR TEVA RIGHT NOW; 27/04/2018 – Teva” Presents New Long-Term Data Demonstrating Efficacy and Safety of COPAXONE 40 Mg/mL; 26/03/2018 – VANDA PHARMACEUTICALS – ON MARCH 23, GOT PARAGRAPH IV CERTIFICATION NOTICE LETTER REGARDING ANDA BY TEVA FOR GENERIC VERSION OF 20MG HETLIOZ CAPSULE; 23/05/2018 – TEVA PHARMACEUTICAL INDUSTRIES LTD – PRESCRIPTION DRUG USER FEE ACT (PDUFA) ACTION DATE FOR FREMANEZUMAB IS SET FOR SEPTEMBER 16; 15/05/2018 – Eli Lilly touts some mixed PhIII results for cluster headaches as Amgen, Novartis prep a market-busting move in migraine $LLY $AMGN $NVS $TEVA; 06/03/2018 – STAT Plus: McCaskill accuses Teva of ‘stonewalling’ her probe into the opioid crisis; 06/03/2018 – TALK: TEVA PHARMACEUTICAL USD 6Y 6%-6.25%, 10Y 7-7.25%; 19/04/2018 – TEVA & PROCTER HAVE AGREED TO TERMINATE PGT HEALTHCARE PACT
Css Llc, which manages about $2.01B US Long portfolio, decreased its stake in Ishares Tr (Call) (FXI) by 17,700 shares to 1,000 shares, valued at $47,000 in 2018Q1, according to the filing. It also reduced its holding in Marriott Intl Inc New (NASDAQ:MAR) by 3,800 shares in the quarter, leaving it with 2,794 shares, and cut its stake in Gabelli Globl Util & Income (NYSEMKT:GLU).
More notable recent Teva Pharmaceutical Industries Limited (NYSE:TEVA) news were published by: Finance.Yahoo.com which released: “Teva Pharmaceutical Industries Limited Stock Still Is a Deep Value Play” on June 15, 2018, also Finance.Yahoo.com with their article: “Warren Buffett Loves TEVA Stock and You Should Too” published on May 23, 2018, Businesswire.com published: “Teva Provides Update on Clinical Trial of Fremanezumab for Use in Chronic Cluster Headache” on June 15, 2018. More interesting news about Teva Pharmaceutical Industries Limited (NYSE:TEVA) were released by: Streetinsider.com and their article: “Wells Fargo Upgrades Teva Pharma (TEVA) to Market Perform” published on June 18, 2018 as well as Globes.Co.Il‘s news article titled: “Tue: Teva rally fails to lift TASE” with publication date: June 12, 2018.
Among 35 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 7 Sell and 19 Hold. Therefore 26% are positive. Teva Pharma has $86 highest and $8 lowest target. $28.50’s average target is 18.50% above currents $24.05 stock price. Teva Pharma had 158 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was initiated by Credit Suisse on Wednesday, May 4 with “Neutral”. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) earned “Buy” rating by Susquehanna on Thursday, January 25. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) earned “Hold” rating by BTIG Research on Thursday, February 1. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) has “Equal-Weight” rating given on Monday, August 7 by Barclays Capital. The stock has “Equal-Weight” rating by Morgan Stanley on Wednesday, November 16. The stock has “Neutral” rating by Nomura on Tuesday, September 29. Citigroup upgraded the stock to “Buy” rating in Thursday, January 4 report. The firm has “Sell” rating given on Monday, June 11 by Leerink Swann. The stock has “Hold” rating by Oppenheimer on Wednesday, October 4. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) earned “Hold” rating by Mizuho on Wednesday, October 4.
Among 56 analysts covering Apple Inc. (NASDAQ:AAPL), 36 have Buy rating, 1 Sell and 19 Hold. Therefore 64% are positive. Apple Inc. has $235 highest and $11 lowest target. $176.35’s average target is -5.03% below currents $185.69 stock price. Apple Inc. had 421 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Friday, September 11 by BMO Capital Markets. The company was maintained on Wednesday, October 12 by UBS. The company was maintained on Thursday, October 13 by Pacific Crest. The rating was maintained by Macquarie Research on Tuesday, September 1 with “Buy”. The stock has “Perform” rating by Oppenheimer on Wednesday, April 27. Canaccord Genuity maintained the shares of AAPL in report on Friday, February 2 with “Buy” rating. Macquarie Research maintained the shares of AAPL in report on Friday, January 20 with “Outperform” rating. The stock of Apple Inc. (NASDAQ:AAPL) earned “Outperform” rating by FBR Capital on Wednesday, January 27. The stock of Apple Inc. (NASDAQ:AAPL) has “Buy” rating given on Friday, March 24 by Nomura. The rating was maintained by Citigroup on Friday, November 3 with “Buy”.
Symmetry Peak Management Llc, which manages about $356.28 million US Long portfolio, decreased its stake in Salesforce Com Inc (NYSE:CRM) by 112,500 shares to 17,500 shares, valued at $2.04 million in 2018Q1, according to the filing. It also reduced its holding in Twilio Inc (Call) by 89,900 shares in the quarter, leaving it with 25,000 shares, and cut its stake in Shake Shack Inc.
Since January 5, 2018, it had 0 insider purchases, and 13 insider sales for $52.34 million activity. On Wednesday, May 23 the insider Srouji Johny sold $2.81M. Another trade for 15,653 shares valued at $2.99M was made by WILLIAMS JEFFREY E on Friday, June 8. 4,867 shares were sold by KONDO CHRIS, worth $910,129 on Wednesday, May 16. $6.83M worth of Apple Inc. (NASDAQ:AAPL) was sold by Maestri Luca on Thursday, April 12. 35,000 shares valued at $6.51 million were sold by LEVINSON ARTHUR D on Wednesday, May 9. $11.56 million worth of Apple Inc. (NASDAQ:AAPL) shares were sold by SCHILLER PHILIP W.
Investors sentiment decreased to 0.69 in Q1 2018. Its down 0.04, from 0.73 in 2017Q4. It dropped, as 69 investors sold AAPL shares while 1039 reduced holdings. 125 funds opened positions while 645 raised stakes. 2.86 billion shares or 3.74% less from 2.98 billion shares in 2017Q4 were reported. Sheets Smith Wealth Management has invested 1.73% in Apple Inc. (NASDAQ:AAPL). Wells Fargo & Company Mn invested in 1.34% or 26.95 million shares. 233,439 were reported by Peapack Gladstone Corporation. Glenview Savings Bank Tru Dept stated it has 77,171 shares. Cheviot Value Ltd Com has invested 3.57% in Apple Inc. (NASDAQ:AAPL). Gratry Llc accumulated 1,635 shares or 0.38% of the stock. Grace & White Ny holds 0.09% of its portfolio in Apple Inc. (NASDAQ:AAPL) for 2,607 shares. Baldwin Brothers Ma holds 4.19% of its portfolio in Apple Inc. (NASDAQ:AAPL) for 154,533 shares. Glovista Invests Ltd accumulated 4,377 shares or 0.16% of the stock. Pinebridge Lp has invested 1.59% in Apple Inc. (NASDAQ:AAPL). Exxonmobil Invest Incorporated Tx reported 3.76% stake. 4,398 were reported by Boothbay Fund Lc. Madrona Financial Svcs Ltd Liability accumulated 0.67% or 5,050 shares. Nottingham Advsr holds 0.06% or 2,231 shares in its portfolio. Exchange Cap Management reported 41,217 shares stake.